San Diego-primarily based Viking Therapeutics marked itself as a serious competitor inside the weight loss drug marketplace in February just after revealing promising info from the mid-phase demo of experimental drug VK2735, which proposed it rivaled—and outperformed—Novo and Lilly drugs when provided as being a weekly injection and in March th